A Naturalistic Study on the Cost Reduction and Efficacy of Long-acting Antipsychotics in an Early Intervention Programme for Patients with Recent-onset Psychosis
Pharmacopsychiatry · 29.05.2026
DOI: 10.1055/a-2865-3839 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacopsychiatry, erschienen am 29.05.2026. Verfasst von MariaJose Acuña und 7 weiteren Autor:innen. Beteiligte Einrichtung: Andalusian Health Service District Sur de Sevilla, Mental Health Clinical Unit of the Southern Health Area of Sevilla, Spain, Seville.
Abstract (Originalsprache)
Introduction
This study aimed to evaluate the impact of treatment with long-acting injectable antipsychotics on direct healthcare costs in a programme for patients with recent-onset psychosis.
Methods
This was an observational, retrospective study. We included all patients admitted to the programme (from July 2015 to April 2020). All costs were recorded and three groups were compared: those receiving oral antipsychotics; those receiving oral treatment initially but subsequently switching before long-acting injectable antipsychotics; and those receiving after long-acting injectable antipsychotics.
Results
A total of 136 patients were included: 68 patients in the oral antipsychotics group and 34 patients in each of the other two groups. The average total healthcare cost per person/y was €11,347 in the oral antipsychotics group, €49,001 in the before long-acting injectable antipsychotics group, and €27,170 in the after long-acting injectable antipsychotics group. The comparisons between the first group and the other two were significant and between the after long-acting injectable antipsychotics vs before long-acting injectable antipsychotics groups (p
Autor:innen und Institutionen
- Andalusian Health Service District Sur de Sevilla, Mental Health Clinical Unit of the Southern Health Area of Sevilla, Spain, Seville.
ORCID-Profile: MariaJose Acuña
Zitieren
APA
Acuña, M., Martin-Muñoz, J. C., Muñoz, M. J., Casado, F. D., Blanco-Venzalá, M., Rosado-Tejero, L., Utrera-Caballero, E., & Galafate, J. J. (2026). A Naturalistic Study on the Cost Reduction and Efficacy of Long-acting Antipsychotics in an Early Intervention Programme for Patients with Recent-onset Psychosis. Pharmacopsychiatry. https://doi.org/10.1055/a-2865-3839
Vancouver
Acuña M, Martin-Muñoz JC, Muñoz MJ, Casado FD, Blanco-Venzalá M, Rosado-Tejero L, et al. A Naturalistic Study on the Cost Reduction and Efficacy of Long-acting Antipsychotics in an Early Intervention Programme for Patients with Recent-onset Psychosis. Pharmacopsychiatry. 2026. doi:10.1055/a-2865-3839
BibTeX
@article{Acua2026,
author = {Acuña, MariaJose and Martin-Muñoz, Joaquin-Carlos and Muñoz, María-Jesús and Casado, Francisco-Dionisio and Blanco-Venzalá, Matilde and Rosado-Tejero, Luisa and Utrera-Caballero, Eva and Galafate, Juan-José},
title = {A Naturalistic Study on the Cost Reduction and Efficacy of Long-acting Antipsychotics in an Early Intervention Programme for Patients with Recent-onset Psychosis},
journal = {Pharmacopsychiatry},
year = {2026},
doi = {10.1055/a-2865-3839}
}
EUVIMED